Description

3-Ribofuranosyl-4,9-Dihydro-4,6,7-Trimethyl-9-Oxoimidazo(1,2-A)Purine is a specialized nucleoside analog with a complex heterocyclic structure, serving as a critical building block in advanced pharmaceutical research and development. This compound matters for its role as a key synthetic intermediate in the creation of novel therapeutic agents, particularly in antiviral and anticancer drug discovery programs. Pharmaceutical R&D laboratories, fine chemical manufacturers, and academic research institutions require this high-purity intermediate to explore new mechanisms of action and develop next-generation medications.

Application

• Pharmaceutical Intermediate: A crucial precursor in the synthesis of novel nucleoside-based antiviral and anticancer drug candidates.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies to investigate purine metabolism and related biological pathways.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies to optimize drug potency and selectivity.
• Reference Standard: Employed as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Process Chemistry Development: Utilized in scaling up synthetic routes for potential active pharmaceutical ingredients (APIs).

Basic Information

Product Name	3-Ribofuranosyl-4,9-Dihydro-4,6,7-Trimethyl-9-Oxoimidazo(1,2-A)Purine
CAS No.	108274-04-0
Molecular Formula	C15H19N5O5
Molecular Weight	349.34 g/mol
Synonyms	9-Oxo-4,6,7-trimethyl-3-ribofuranosyl-4,9-dihydroimidazo[1,2-a]purine; 3-β-D-Ribofuranosyl-4,9-dihydro-4,6,7-trimethyl-9-oxoimidazo[1,2-a]purine; Imidazo[1,2-a]purine ribonucleoside derivative; NSC 694501; 4,9-Dihydro-4,6,7-trimethyl-9-oxo-3-β-D-ribofuranosylimidazo[1,2-a]purine
EINECS	Contact for details

Quality Control

Our 3-Ribofuranosyl-4,9-Dihydro-4,6,7-Trimethyl-9-Oxoimidazo(1,2-A)Purine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing purity, impurities, and analytical methods are available for every shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.